ACTU vs DAL · $49.0M cap vs P/E 12, rev $61.64B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
ACTU does not have a complete income-statement cache yet.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
ACTU currently screens at market cap $49.0M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the ACTU and DAL stock pages for the full models.
Not investment advice.